Torthaí cuardaigh - Kate Talks

  • 1 - 8 toradh as 8 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

    Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival de réir Alexandra Giatromanolaki, Michael I. Koukourakis, Efthimios Sivridis, Helen Turley, Kate Talks, Francesco Pezzella, Kevin C. Gatter, Adrian L. Harris

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B

    Guidelines on the use of prophylactic factor replacement for children and adults with Haemophilia A and B de réir Rachel Rayment, Elizabeth Chalmers, Katherine E. Law, Richard Gooding, Anne M. Kelly, Susan Shapiro, Kate Talks, Oliver Tunstall, Tina Biss

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Diagnosis and management of acquired coagulation inhibitors: a guideline from <scp>UKHCDO</scp>

    Diagnosis and management of acquired coagulation inhibitors: a guideline from <scp>UKHCDO</scp> de réir Peter W. Collins, Elizabeth Chalmers, Daniel P. Hart, Ian Jennings, Ri Liesner, Savita Rangarajan, Kate Talks, Michael D. Williams, C. R. M. Hay

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee

    Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Ex... de réir Peter W. Collins, Ri Liesner, Michael Makris, Kate Talks, Pratima Chowdary, Elizabeth Chalmers, Georgina Hall, Anne Riddell, Charles Percy, C. R. M. Hay, Daniel P. Hart

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia

    Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia de réir Charlotte Bradbury, Julie Pell, Quentin A. Hill, Catherine Bagot, Nichola Cooper, Jenny Ingram, Katie Breheny, Rebecca Kandiyali, Rachel Rayment, Gillian Evans, Kate Talks, Ian Thomas, Rosemary Greenwood

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Induction of Endothelial PAS Domain Protein-1 by Hypoxia: Characterization and Comparison With Hypoxia-Inducible Factor-1α

    Induction of Endothelial PAS Domain Protein-1 by Hypoxia: Characterization and Comparison With Hypoxia-Inducible Factor-1α de réir Michael S. Wiesener, Helen Turley, William E. Allen, Carsten Willam, Kai‐Uwe Eckardt, Kate Talks, S.M. Wood, Kevin C. Gatter, Adrian L. Harris, Christopher W. Pugh, Peter J. Ratcliffe, Patrick H. Maxwell

    Foilsithe / Cruthaithe 1998
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B

    Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B de réir Pratima Chowdary, Susan Shapiro, Michael Makris, Gillian Evans, Sara Boyce, Kate Talks, Gerard Dolan, Ulrike M. Reiss, Mark Phillips, Anne Riddell, Maria R. Peralta, Michelle Quaye, David Patch, Edward G. D. Tuddenham, Allison Dane, Marie Watissée, Alison Long, Amit C. Nathwani

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the <scp>TRAIT</scp> study

    Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the <scp>TRAIT</scp> study de réir Nichola Cooper, Marie Scully, Charles Percy, Phillip L. R. Nicolson, Gillian Lowe, Catherine Bagot, Jecko Thachil, H. Grech, Tim Nokes, Quentin A. Hill, Charlotte Bradbury, Kate Talks, Tina Dutt, Gillian Evans, Sue Pavord, Sarah Wexler, Asad Charania, Sarah J. Collington, Andrew Ervin, Nicholas Ramscar, Drew Provan

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: